Read + Share
Amedeo Smart
Independent Medical Education
Ye F, Wang L, Qian Y, Deng W, et al. Imatinib and blinatumomab successfully rescued a pediatric B-ALL patient with TERF2::PDGFRB fusion resistant to dasatinib and chemotherapy. Ann Hematol 2025;104:5507-5512.PMID: 40974379
Email
LinkedIn
Privacy Policy